Tromboxano A2 (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tromboxano A2" in Galician language version.

refsWebsite

Global rank Galician rank

7doi.org

2^nd place

7^th place

6nih.gov

4^th place

6^th place

4worldcat.org

5^th place

11^th place

2web.archive.org

1^st place

1licor.com

low place

1pnas.org

1,293^rd place

271^st place

doi.org

dx.doi.org

Ding, Xueqin; Murray, Paul A. (November 2005). "Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins". American Journal of Physiology. Lung Cellular and Molecular Physiology 289 (5): L825–833. ISSN 1040-0605. PMID 15964897. doi:10.1152/ajplung.00177.2005.
Yamamoto, K.; Ebina, S.; Nakanishi, H.; Nakahata, N. (November 1995). "Thromboxane A2 receptor-mediated signal transduction in rabbit aortic smooth muscle cells". General Pharmacology 26 (7): 1489–1498. ISSN 0306-3623. PMID 8690235. doi:10.1016/0306-3623(95)00025-9.
Smyth, Emer M (2010-04-01). "Thromboxane and the thromboxane receptor in cardiovascular disease". Clinical lipidology 5 (2): 209–219. ISSN 1758-4299. PMC 2882156. PMID 20543887. doi:10.2217/CLP.10.11.
Winn, R; Harlan, J; Nadir, B; Harker, L; Hildebrandt, J (September 1983). "Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.". Journal of Clinical Investigation 72 (3): 911–918. ISSN 0021-9738. PMC 1129256. PMID 6886010. doi:10.1172/jci111062.
Yokomizo, T. (2014). "Two distinct leukotriene B4 receptors, BLT1 and BLT2". Journal of Biochemistry 157: 65–71. doi:10.1093/jb/mvu078.
Catella F, Healy D, Lawson JA, FitzGerald GA (1986). "11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation". PNAS 83 (16): 5861–5865. PMC 386396. PMID 3461463. doi:10.1073/pnas.83.16.5861. Arquivado dende o orixinal o 23 de outubro de 2015. Consultado o 20 de setembro de 2018.
Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG (2007). "A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease". Eur Heart J 28 (14): 1702–1708. PMID 17569678. doi:10.1093/eurheartj/ehm226.

licor.com

biosupport.licor.com

Michael P. Walsh; et al. "Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855 but not Thr-697" (PDF). Arquivado dende o orixinal (PDF) o 13 de xullo de 2011. Consultado o 20 de setembro de 2018.

nih.gov

ncbi.nlm.nih.gov

Ding, Xueqin; Murray, Paul A. (November 2005). "Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins". American Journal of Physiology. Lung Cellular and Molecular Physiology 289 (5): L825–833. ISSN 1040-0605. PMID 15964897. doi:10.1152/ajplung.00177.2005.
Yamamoto, K.; Ebina, S.; Nakanishi, H.; Nakahata, N. (November 1995). "Thromboxane A2 receptor-mediated signal transduction in rabbit aortic smooth muscle cells". General Pharmacology 26 (7): 1489–1498. ISSN 0306-3623. PMID 8690235. doi:10.1016/0306-3623(95)00025-9.
Smyth, Emer M (2010-04-01). "Thromboxane and the thromboxane receptor in cardiovascular disease". Clinical lipidology 5 (2): 209–219. ISSN 1758-4299. PMC 2882156. PMID 20543887. doi:10.2217/CLP.10.11.
Winn, R; Harlan, J; Nadir, B; Harker, L; Hildebrandt, J (September 1983). "Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.". Journal of Clinical Investigation 72 (3): 911–918. ISSN 0021-9738. PMC 1129256. PMID 6886010. doi:10.1172/jci111062.
Catella F, Healy D, Lawson JA, FitzGerald GA (1986). "11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation". PNAS 83 (16): 5861–5865. PMC 386396. PMID 3461463. doi:10.1073/pnas.83.16.5861. Arquivado dende o orixinal o 23 de outubro de 2015. Consultado o 20 de setembro de 2018.
Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG (2007). "A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease". Eur Heart J 28 (14): 1702–1708. PMID 17569678. doi:10.1093/eurheartj/ehm226.

pnas.org

Catella F, Healy D, Lawson JA, FitzGerald GA (1986). "11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation". PNAS 83 (16): 5861–5865. PMC 386396. PMID 3461463. doi:10.1073/pnas.83.16.5861. Arquivado dende o orixinal o 23 de outubro de 2015. Consultado o 20 de setembro de 2018.

web.archive.org

Michael P. Walsh; et al. "Thromboxane A2-induced contraction of rat caudal arterial smooth muscle involves activation of Ca2+ entry and Ca2+sensitization: Rho-associated kinase-mediated phosphorylation of MYPT1 at Thr-855 but not Thr-697" (PDF). Arquivado dende o orixinal (PDF) o 13 de xullo de 2011. Consultado o 20 de setembro de 2018.
Catella F, Healy D, Lawson JA, FitzGerald GA (1986). "11-Dehydrothromboxane B2: a quantitative index of thromboxane A2 formation in the human circulation". PNAS 83 (16): 5861–5865. PMC 386396. PMID 3461463. doi:10.1073/pnas.83.16.5861. Arquivado dende o orixinal o 23 de outubro de 2015. Consultado o 20 de setembro de 2018.

worldcat.org

Ding, Xueqin; Murray, Paul A. (November 2005). "Cellular mechanisms of thromboxane A2-mediated contraction in pulmonary veins". American Journal of Physiology. Lung Cellular and Molecular Physiology 289 (5): L825–833. ISSN 1040-0605. PMID 15964897. doi:10.1152/ajplung.00177.2005.
Yamamoto, K.; Ebina, S.; Nakanishi, H.; Nakahata, N. (November 1995). "Thromboxane A2 receptor-mediated signal transduction in rabbit aortic smooth muscle cells". General Pharmacology 26 (7): 1489–1498. ISSN 0306-3623. PMID 8690235. doi:10.1016/0306-3623(95)00025-9.
Smyth, Emer M (2010-04-01). "Thromboxane and the thromboxane receptor in cardiovascular disease". Clinical lipidology 5 (2): 209–219. ISSN 1758-4299. PMC 2882156. PMID 20543887. doi:10.2217/CLP.10.11.
Winn, R; Harlan, J; Nadir, B; Harker, L; Hildebrandt, J (September 1983). "Thromboxane A2 mediates lung vasoconstriction but not permeability after endotoxin.". Journal of Clinical Investigation 72 (3): 911–918. ISSN 0021-9738. PMC 1129256. PMID 6886010. doi:10.1172/jci111062.